首页 > 最新文献

Klinicka Onkologie最新文献

英文 中文
Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy 恩杂鲁胺和阿比特龙治疗转移性去势抵抗性前列腺癌患者先前接受化疗
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023300
Sofya Al-Samsam, J. Bartoš, V. Šámal, J. Dvořák, H. Kolářová, I. Richter
{"title":"Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy","authors":"Sofya Al-Samsam, J. Bartoš, V. Šámal, J. Dvořák, H. Kolářová, I. Richter","doi":"10.48095/ccko2023300","DOIUrl":"https://doi.org/10.48095/ccko2023300","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70560464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapy of Castleman’s disease with siltuximab – case report and review of literature 西妥昔单抗治疗Castleman病1例报告及文献复习
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023320
Z. Adam, D. Zeman, Aleš Chodacki, L. Pour, Teodor Horváth, P. Benda, Z. Adamová, M. Krejci, M. Tomíška, I. Boichuk, Z. Král
{"title":"Therapy of Castleman’s disease with siltuximab – case report and review of literature","authors":"Z. Adam, D. Zeman, Aleš Chodacki, L. Pour, Teodor Horváth, P. Benda, Z. Adamová, M. Krejci, M. Tomíška, I. Boichuk, Z. Král","doi":"10.48095/ccko2023320","DOIUrl":"https://doi.org/10.48095/ccko2023320","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49524087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma 循环游离DNA及其在恶性淋巴瘤诊断和治疗中的潜力
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023273
S. Hricko, V. Navrkalova, A. Janíková
{"title":"Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma","authors":"S. Hricko, V. Navrkalova, A. Janíková","doi":"10.48095/ccko2023273","DOIUrl":"https://doi.org/10.48095/ccko2023273","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46967380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ewing‘s sarcoma of the urinary bladder – the urologic and pathologic differential diagnosis and current therapeutic options 膀胱尤文氏肉瘤-泌尿学和病理鉴别诊断和目前的治疗选择
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023314
M. Král, Michaela Kurfürstová, I. Hartmann, H. Študentová, Jozef Škarda
{"title":"Ewing‘s sarcoma of the urinary bladder – the urologic and pathologic differential diagnosis and current therapeutic options","authors":"M. Král, Michaela Kurfürstová, I. Hartmann, H. Študentová, Jozef Škarda","doi":"10.48095/ccko2023314","DOIUrl":"https://doi.org/10.48095/ccko2023314","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47363474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
News in the fifth edition of World Health Organization classification of testicular tumors 世界卫生组织睾丸肿瘤分类第五版新闻
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023268
Samuel Horák, Z. Cierna
{"title":"News in the fifth edition of World Health Organization classification of testicular tumors","authors":"Samuel Horák, Z. Cierna","doi":"10.48095/ccko2023268","DOIUrl":"https://doi.org/10.48095/ccko2023268","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43063407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurobiology of multiple myeloma and its therapeutical use – results of the pilot study with a control arm 多发性骨髓瘤的神经生物学及其治疗用途——对照试验研究的结果
Q4 Medicine Pub Date : 2023-08-15 DOI: 10.48095/ccko2023287
P. Kotouček, R. Enright, Stanislava Gregor Sorgerová, Ľ. Hunáková, Veronika Chlebcová, D. Cholujová, J. Jakubikova, B. Mravec, E. Naništová, Ľudmila Paneková, J. Sedlák
{"title":"Neurobiology of multiple myeloma and its therapeutical use – results of the pilot study with a control arm","authors":"P. Kotouček, R. Enright, Stanislava Gregor Sorgerová, Ľ. Hunáková, Veronika Chlebcová, D. Cholujová, J. Jakubikova, B. Mravec, E. Naništová, Ľudmila Paneková, J. Sedlák","doi":"10.48095/ccko2023287","DOIUrl":"https://doi.org/10.48095/ccko2023287","url":null,"abstract":"","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47751465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of immunotherapy in a young patient with mismatch repair-deficient rectal cancer - a case report. 免疫治疗对年轻错配修复缺陷直肠癌患者的影响- 1例报告。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.48095/ccko2023241
T Sokop, R Obermannová

Background: The incidence of colorectal cancer (CRC) in the age group of young patients has been increasing. Furthermore, in these patients, CRC is more frequently an aggressive histological type of tumor, diagnosed in the late clinical stages of the disease. Another characteristic feature is a higher frequency of mismatch repair deficient (dMMR) tumors, in the treatment of which immunotherapy can be an effective treatment modality, used to prolong overall survival and improve quality of life. Conversely, the effect of chemotherapy may be lower.

Case: We present the case of a 35year-old patient treated with primary therapy for locally advanced dMMR rectal cancer. Neoadjuvant chemoradiotherapy was followed by rectal resection, which was accompanied by serious postoperative complications. In addition, there was an early local relapse of the disease, resistant to systemic chemotherapy treatment. After the progression of the disease, second line of the treatment with pembrolizumab was initiated.

Results: The treatment with pembrolizumab led to a partial regression of the disease and subsequently its stabilization, which has been lasting for 15 months. The improvement of the patient's quality of life, e. g. stabilization of the blood count and regression of diarrhea, is a significant benefit. In addition, the treatment has been given without the development of serious toxicity, so far.

Conclusion: Microsatellite instability testing in the management of locally advanced and metastatic colorectal cancer is of fundamental importance in setting the appropriate treatment procedures. In the future, we can expect results of several studies that will try to prove the effect of immunotherapy not only in metastatic disease, but also in the neoadjuvant regimen in resectable and potentially resectable dMMR rectal and colon cancers.

背景:结直肠癌(CRC)在年轻患者年龄组的发病率呈上升趋势。此外,在这些患者中,结直肠癌更经常是一种侵袭性的组织学类型的肿瘤,在疾病的晚期临床阶段被诊断出来。另一个特征是高频率的错配修复缺陷(dMMR)肿瘤,在治疗中免疫治疗可以是一种有效的治疗方式,用于延长总生存期和提高生活质量。相反,化疗的效果可能较低。病例:我们提出的情况下,35岁的病人接受原发性治疗局部晚期dMMR直肠癌。新辅助放化疗后行直肠切除术,术后并发症严重。此外,有一个早期的局部复发的疾病,抵抗全身化疗。在病情进展后,开始使用派姆单抗进行二线治疗。结果:pembrolizumab治疗导致疾病部分消退,随后病情稳定,持续了15个月。改善病人的生活质量,例如:血液计数的稳定和腹泻的消退,是一个显著的好处。此外,到目前为止,这种治疗还没有出现严重的毒性。结论:微卫星不稳定性检测在局部晚期和转移性结直肠癌的治疗中具有重要的基础意义。在未来,我们可以期待几项研究的结果,这些研究将试图证明免疫治疗不仅在转移性疾病中有效,而且在可切除和潜在可切除的dMMR直肠癌和结肠癌的新辅助方案中也有效。
{"title":"The effect of immunotherapy in a young patient with mismatch repair-deficient rectal cancer - a case report.","authors":"T Sokop,&nbsp;R Obermannová","doi":"10.48095/ccko2023241","DOIUrl":"https://doi.org/10.48095/ccko2023241","url":null,"abstract":"<p><strong>Background: </strong>The incidence of colorectal cancer (CRC) in the age group of young patients has been increasing. Furthermore, in these patients, CRC is more frequently an aggressive histological type of tumor, diagnosed in the late clinical stages of the disease. Another characteristic feature is a higher frequency of mismatch repair deficient (dMMR) tumors, in the treatment of which immunotherapy can be an effective treatment modality, used to prolong overall survival and improve quality of life. Conversely, the effect of chemotherapy may be lower.</p><p><strong>Case: </strong>We present the case of a 35year-old patient treated with primary therapy for locally advanced dMMR rectal cancer. Neoadjuvant chemoradiotherapy was followed by rectal resection, which was accompanied by serious postoperative complications. In addition, there was an early local relapse of the disease, resistant to systemic chemotherapy treatment. After the progression of the disease, second line of the treatment with pembrolizumab was initiated.</p><p><strong>Results: </strong>The treatment with pembrolizumab led to a partial regression of the disease and subsequently its stabilization, which has been lasting for 15 months. The improvement of the patient's quality of life, e. g. stabilization of the blood count and regression of diarrhea, is a significant benefit. In addition, the treatment has been given without the development of serious toxicity, so far.</p><p><strong>Conclusion: </strong>Microsatellite instability testing in the management of locally advanced and metastatic colorectal cancer is of fundamental importance in setting the appropriate treatment procedures. In the future, we can expect results of several studies that will try to prove the effect of immunotherapy not only in metastatic disease, but also in the neoadjuvant regimen in resectable and potentially resectable dMMR rectal and colon cancers.</p>","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"36 3","pages":"241-245"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9684794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected trends in head and neck cancer epidemiology in Slovakia - an international comparison. 斯洛伐克头颈癌流行病学的选定趋势——国际比较。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.48095/ccko2023135
M Ondrušová, M Suchanský, D Ondruš, S Marková

Background: Head-and-neck malignant neoplasms (diagnosis group C00-C14, according to ICD-10) form a heterogeneous group of diseases with close anatomical localization. The incidence is twice to three times higher in men than in women and is increasing worldwide.

Objective: The aim of our analysis was to estimate changes of incidence and mortality rates of head-and-neck malignancies associated with anatomical topographic regions over the time as well as to compare these indicators in different selected countries of the world. Secondary endpoints included the assessment of patients' age distribution, clinical stages of newly diagnosed cases, and point prevalence of the disease in the Slovak Republic (SR).

Material and methods: The data base for the calculations was obtained from national databases and outputs of the National Cancer Registry (NCR) of the SR (with summary data available from the National Epidemiological Portal of Malignant Tumors, which analyzed data from 1984-2003 and was available until 2009, the remaining data were obtained from annual analyses of the NCR of the SR and the National Centre for Health Information (NCZI)), from the Statistical Office of the SR, and from the IARC WHO global database outputs on incidence, mortality, prevalence and survival of the patients. Incidence and mortality data in the SR were available up to 2012 (including) and up to 2021 (including), respectively. A log-linear joinpoint regression model was used to analyze the development of incidence and mortality rates over time by using Joinpoint Regression Program software. To achieve maximum precision in the estimated total surviving population of patients with head and neck malignant neoplasms, a model was developed to calculate the point (overall) prevalence based on absolute numbers of long-term registered national counts of newly diagnosed patients, mortality from the disease, overall mortality, and survival probability. The representation of clinical stages of head and neck carcinoma in the SR was compiled from available national data (2000-2012) and from predictions and does not consider changes in TNM classifications over the time.

Results: The age-adjusted (to the world standard population, ASR-W) incidence rate and the age-adjusted (ASR-W) mortality rate of head-and-neck malignant tumors in the SR have shown a significantly decreasing tendency in men since 1990; however, in women both of these indicators have shown a significant increasing tendency, especially the significantly growing incidence since 2004. In 2012, the overall age-adjusted incidence and mortality rate of head-and-neck cancers in the SR were significantly higher in males (ASR-W incidence 22.6/100,000 and ASR-W mortality 15.26/100,000) compared to females (ASR-W incidence 4.21/100,000 and ASR-W mortality 1.52/100,000). More than 75% of newly diagnosed cases are already in advanced and metastat

背景:头颈部恶性肿瘤(ICD-10诊断组C00-C14)是一种异质性疾病,解剖定位密切。男性的发病率是女性的两到三倍,并且在世界范围内呈上升趋势。目的:我们分析的目的是估计与解剖地形区域相关的头颈部恶性肿瘤的发病率和死亡率随时间的变化,并比较世界上不同国家的这些指标。次要终点包括评估患者的年龄分布、新诊断病例的临床分期和斯洛伐克共和国(SR)疾病的点患病率。材料和方法:计算的数据库来自社会主义共和国统计局的国家数据库和国家癌症登记处的输出(其中汇总数据来自国家恶性肿瘤流行病学门户网站,该网站分析了1984-2003年的数据,并提供至2009年,其余数据来自社会主义共和国统计局对国家癌症登记处和国家卫生信息中心的年度分析)。以及来自国际癌症研究机构世卫组织关于患者发病率、死亡率、患病率和生存率的全球数据库输出。SR的发病率和死亡率数据分别可获得至2012年(包括)和至2021年(包括)的数据。采用对数线性连接点回归模型,利用连接点回归程序分析发病率和死亡率随时间的变化。为了最大限度地精确估计头颈部恶性肿瘤患者的总存活人群,开发了一个模型,根据长期登记的全国新诊断患者数量的绝对数字、疾病死亡率、总死亡率和生存概率来计算点(总体)患病率。SR中头颈癌临床分期的代表是根据现有的国家数据(2000-2012年)和预测编制的,没有考虑TNM分类随时间的变化。结果:自1990年以来,SR地区男性头颈部恶性肿瘤的年龄校正(世界标准人群,ASR-W)发病率和年龄校正(ASR-W)死亡率呈显著下降趋势;然而,在妇女中,这两项指标都显示出显著增加的趋势,特别是自2004年以来发病率显著增加。2012年,SR地区男性头颈癌总体年龄调整发病率和死亡率(ASR-W发病率为22.6/10万,死亡率为15.26/10万)明显高于女性(ASR-W发病率为4.21/10万,死亡率为1.52/10万)。超过75%的新诊断病例已经处于晚期和转移性临床阶段,这是最不利的生存因素。到2021年,这些患者在SR中的绝对患病率估计为N = 9,395。结论:有必要掌握最新的流行病学概况,以便制定肿瘤预防和干预方案。
{"title":"Selected trends in head and neck cancer epidemiology in Slovakia - an international comparison.","authors":"M Ondrušová,&nbsp;M Suchanský,&nbsp;D Ondruš,&nbsp;S Marková","doi":"10.48095/ccko2023135","DOIUrl":"https://doi.org/10.48095/ccko2023135","url":null,"abstract":"<p><strong>Background: </strong>Head-and-neck malignant neoplasms (diagnosis group C00-C14, according to ICD-10) form a heterogeneous group of diseases with close anatomical localization. The incidence is twice to three times higher in men than in women and is increasing worldwide.</p><p><strong>Objective: </strong>The aim of our analysis was to estimate changes of incidence and mortality rates of head-and-neck malignancies associated with anatomical topographic regions over the time as well as to compare these indicators in different selected countries of the world. Secondary endpoints included the assessment of patients' age distribution, clinical stages of newly diagnosed cases, and point prevalence of the disease in the Slovak Republic (SR).</p><p><strong>Material and methods: </strong>The data base for the calculations was obtained from national databases and outputs of the National Cancer Registry (NCR) of the SR (with summary data available from the National Epidemiological Portal of Malignant Tumors, which analyzed data from 1984-2003 and was available until 2009, the remaining data were obtained from annual analyses of the NCR of the SR and the National Centre for Health Information (NCZI)), from the Statistical Office of the SR, and from the IARC WHO global database outputs on incidence, mortality, prevalence and survival of the patients. Incidence and mortality data in the SR were available up to 2012 (including) and up to 2021 (including), respectively. A log-linear joinpoint regression model was used to analyze the development of incidence and mortality rates over time by using Joinpoint Regression Program software. To achieve maximum precision in the estimated total surviving population of patients with head and neck malignant neoplasms, a model was developed to calculate the point (overall) prevalence based on absolute numbers of long-term registered national counts of newly diagnosed patients, mortality from the disease, overall mortality, and survival probability. The representation of clinical stages of head and neck carcinoma in the SR was compiled from available national data (2000-2012) and from predictions and does not consider changes in TNM classifications over the time.</p><p><strong>Results: </strong>The age-adjusted (to the world standard population, ASR-W) incidence rate and the age-adjusted (ASR-W) mortality rate of head-and-neck malignant tumors in the SR have shown a significantly decreasing tendency in men since 1990; however, in women both of these indicators have shown a significant increasing tendency, especially the significantly growing incidence since 2004. In 2012, the overall age-adjusted incidence and mortality rate of head-and-neck cancers in the SR were significantly higher in males (ASR-W incidence 22.6/100,000 and ASR-W mortality 15.26/100,000) compared to females (ASR-W incidence 4.21/100,000 and ASR-W mortality 1.52/100,000). More than 75% of newly diagnosed cases are already in advanced and metastat","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"36 2","pages":"135-142"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9788572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How patients can help us be even better doctors - educational leaflet "Before I go to the doctor". 患者如何帮助我们成为更好的医生--"看病之前 "教育传单。
Q4 Medicine Pub Date : 2023-01-01
M Světlák, V Šnajdrová, K Fialová

Background: Medical psychology research shows that how a patient communicates appears to be the strongest predictor of physician behavior during a consultation and that patient's activity also influences how much information a physician communicates to a patient about his or her illness and treatment. Thus, being a patient is a skill that needs to be developed to balance the responsibilities of doctors and patients in each of their encounters. There is a lack of clear recommendations and education in this area, and patients' behaviour is instead governed by the etiquette of courtesy.

Purpose: The main aim of this article is to create a list of recommendations for patients and physicians to develop the skill of a competent patient in mutual communication and to include these recommendations into an educational leaflet with the aim to support the diagnostic and therapeutic process and personalized care.

Material and methods: Literature sources were selected unsystematically for the purpose of a narrative review, guided by the question: "What patient skills and competencies promote effective communication with the physician?" We adopted the snowball method, sometimes referred to as chain or reference selection, to generate the list.

Results: The results of the current narrative review demonstrate that the topic of patient communication competencies interests researchers and clinicians across medical disciplines. A summary of patient competencies was developed into an educational handout entitled "Before I go to the doctor". The leaflet can be freely distributed in a printed form, as presented in the article, or patients can be referred to its electronic version (via QR code on the leaflet or on the website of the Department of Medical Psychology and Psychosomatics of the Faculty of Medicine, Masaryk University, in the educational materials section at https: //upp.med.muni.cz/zdroje/edu). The educational leaflet can be used as educational material in any healthcare facility.

Conclusion: Being a competent patient is an ideal state that we strive for from the position of patients and physicians in order to develop medicine more symmetrically, in partnership and with an optimal distribution of responsibility for health, illness and treatment. The information leaflet is one of the possible and fundamental interventions to develop the skill of competent communication on the part of the patient. It is the most commonly used communication channel in patient education. The current list of recommendations is not definitive and binding. However, it opens up the topic itself. It names the dimensions of doctor-patient communication and gives both parties the opportunity to consider what their relationship should be like, what is missing in this relationship, and what is important to both parties.

背景:医学心理学研究表明,患者的沟通方式似乎是医生在诊疗过程中行为的最有力预测因素,患者的活动也会影响医生向患者传达多少有关其疾病和治疗的信息。因此,做病人是一项需要培养的技能,以平衡医生和病人在每次接触中的责任。目的:本文的主要目的是为患者和医生制定一份建议清单,以培养患者在相互沟通中的能力,并将这些建议纳入教育宣传册,旨在为诊断和治疗过程以及个性化护理提供支持:材料和方法:以问题为导向,不加系统地选择文献资料进行叙述性综述:"哪些患者技能和能力可促进与医生的有效沟通?我们采用 "滚雪球 "法(有时也称为 "链式 "或 "参考文献选择")来生成列表:本次叙事性综述的结果表明,各医学学科的研究人员和临床医师都对患者沟通能力这一主题很感兴趣。我们将患者沟通能力的摘要编写成了一份题为 "看病之前 "的教育手册。该传单可以像文章中介绍的那样以印刷品的形式免费发放,患者也可以参考其电子版(通过传单上的二维码或马萨里克大学医学院医学心理学和心身医学系网站上的教育资料部分,网址为 https: //upp.med.muni.cz/zdroje/edu )。该教育传单可用作任何医疗机构的教育材料:作为一名称职的患者,是我们从患者和医生的立场出发而努力追求的理想状态,目的是以更加对称、合作的方式发展医学,并对健康、疾病和治疗的责任进行最佳分配。信息传单是培养患者有效沟通技能的可能和基本干预措施之一。它是患者教育中最常用的沟通渠道。目前的建议清单并不具有确定性和约束力。然而,它开启了这一主题本身。它指出了医患沟通的各个层面,让医患双方都有机会思考他们之间的关系应该是怎样的,这种关系中缺少了什么,以及什么对双方来说是重要的。
{"title":"How patients can help us be even better doctors - educational leaflet \"Before I go to the doctor\".","authors":"M Světlák, V Šnajdrová, K Fialová","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Medical psychology research shows that how a patient communicates appears to be the strongest predictor of physician behavior during a consultation and that patient's activity also influences how much information a physician communicates to a patient about his or her illness and treatment. Thus, being a patient is a skill that needs to be developed to balance the responsibilities of doctors and patients in each of their encounters. There is a lack of clear recommendations and education in this area, and patients' behaviour is instead governed by the etiquette of courtesy.</p><p><strong>Purpose: </strong>The main aim of this article is to create a list of recommendations for patients and physicians to develop the skill of a competent patient in mutual communication and to include these recommendations into an educational leaflet with the aim to support the diagnostic and therapeutic process and personalized care.</p><p><strong>Material and methods: </strong>Literature sources were selected unsystematically for the purpose of a narrative review, guided by the question: \"What patient skills and competencies promote effective communication with the physician?\" We adopted the snowball method, sometimes referred to as chain or reference selection, to generate the list.</p><p><strong>Results: </strong>The results of the current narrative review demonstrate that the topic of patient communication competencies interests researchers and clinicians across medical disciplines. A summary of patient competencies was developed into an educational handout entitled \"Before I go to the doctor\". The leaflet can be freely distributed in a printed form, as presented in the article, or patients can be referred to its electronic version (via QR code on the leaflet or on the website of the Department of Medical Psychology and Psychosomatics of the Faculty of Medicine, Masaryk University, in the educational materials section at https: //upp.med.muni.cz/zdroje/edu). The educational leaflet can be used as educational material in any healthcare facility.</p><p><strong>Conclusion: </strong>Being a competent patient is an ideal state that we strive for from the position of patients and physicians in order to develop medicine more symmetrically, in partnership and with an optimal distribution of responsibility for health, illness and treatment. The information leaflet is one of the possible and fundamental interventions to develop the skill of competent communication on the part of the patient. It is the most commonly used communication channel in patient education. The current list of recommendations is not definitive and binding. However, it opens up the topic itself. It names the dimensions of doctor-patient communication and gives both parties the opportunity to consider what their relationship should be like, what is missing in this relationship, and what is important to both parties.</p>","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"37 4","pages":"307-313"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139404668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
News in the fifth edition of World Health Organization classification of testicular tumors. 世界卫生组织睾丸肿瘤分类第五版中的新闻。
Q4 Medicine Pub Date : 2023-01-01
S Horák, Z Čierna

Background: The fifth edition of World Health Organization classification of urinary and male genital tumours also brought news regarding testicular tumours. In contrast to the previous editions' radical alterations, the adjustments in the fifth edition are subtle and mostly impact the terminology, categorization of some of the rare tumours and diagnostic criteria.

Purpose: Acquainting with current terms and tumor classification, which is necessary for good clinical practice.

背景:世界卫生组织第五版泌尿系统和男性生殖器肿瘤分类也带来了有关睾丸肿瘤的新消息。与前几版的彻底改变相比,第五版的调整非常细微,主要影响术语、一些罕见肿瘤的分类和诊断标准。
{"title":"News in the fifth edition of World Health Organization classification of testicular tumors.","authors":"S Horák, Z Čierna","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The fifth edition of World Health Organization classification of urinary and male genital tumours also brought news regarding testicular tumours. In contrast to the previous editions' radical alterations, the adjustments in the fifth edition are subtle and mostly impact the terminology, categorization of some of the rare tumours and diagnostic criteria.</p><p><strong>Purpose: </strong>Acquainting with current terms and tumor classification, which is necessary for good clinical practice.</p>","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":"37 4","pages":"268-272"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139404670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Klinicka Onkologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1